Details of the Drug

General Information of Drug (ID: DMNVZDT)

Drug Name
ISIS-FGFR4
Indication
Disease Entry ICD 11 Status REF
Obesity 5B81 Phase 2 [1]
Drug Type
Antisense drug
Cross-matching ID
TTD ID
D0SL8T

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
FGFR4 messenger RNA (FGFR4 mRNA) TT1KX2S FGFR4_HUMAN Not Available [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT02476019) A Safety, Tolerability, PK, and PD Study of Once Weekly ISIS-FGFR4RX SC in Obese Patients.
2 Clinical pipeline report, company report or official report of ISIS Pharmaceuticals (2011).